Selma Olsson-Åkefeldt

Selma Olsson-Åkefeldt

Auto-generated profile, based on publicly available information

Selma Olsson-Åkefeldt

Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2021 in Acta Paediatrica
Verified
Journal Article
Open access
PDF file
ESEllinor Sterky
Ellinor Sterky
SOSelma Olsson‐Åkefeldt
Selma Olsson‐Åkefeldt
OHOlof Hertting
Olof Hertting
Eric HerleniusEric Herlenius
Eric Herlenius
TATobias Alfven
Tobias Alfven
HHHelena Hildenwall
Helena Hildenwall
Click on the article title to read more.

1 February 2020 in Cytokine
Verified
Journal Article
Closed access
MIMohamad Bachar Ismail
Mohamad Bachar Ismail
SÅSelma Olsson Åkefeldt
Selma Olsson Åkefeldt
MLMagda Lourda
Magda Lourda
DGDésirée Gavhed
Désirée Gavhed
Maurizio AricòMaurizio Aricò
Maurizio Aricò
HVHélène Valentin
Hélène Valentin

25 September 2021 in Infectious Diseases
Verified
Journal Article
Closed access
SOSelma Olsson-Åkefeldt
Selma Olsson-Åkefeldt
MRMaria Rotzén-Östlund
Maria Rotzén-Östlund
BHBerit Hammas
Berit Hammas
MEMargareta Eriksson
Margareta Eriksson
RBRutger Bennet
Rutger Bennet
In Stockholm, Sweden, rotavirus vaccination was offered to children born after 1 March 2014. Our aim was to describe rates of hospitalisation due to community-acquired gastroenteritis before and after the introduction of the vaccine, and aetiology, underlying medical conditions and complications in admitted children. We retrospectively included patients from our catchment area hospitalised with a diagnosis of gastroenteritis during ten infection seasons 2008/2009–2017/2018, whereof six seasons prevaccination and four seasons postvaccination. We studied virus detection data and the patients’ medical records. We included 3718 episodes in 3513 children. In 2967 (80%), stools were tested with virus isolation, ELISA, PCR, or bacterial culture; 479 (16%) tested negative. The incidence rates, with 95% confidence intervals, for children <5 years hospitalised for rotavirus gastroenteritis were 2.9 (2.8–3.1) per 1000 person-years prevaccination and 0.65 (0.56–0.74) postvaccination, for a rate ratio (RR) of 0.22 (0.19–0.26, p < .001). The rates for all-cause gastroenteritis were 5.6 (5.4–5.9) prevaccination and 2.5 (2.3–2.7) postvaccination, RR 0.45 (0.42–0.50, p < .001). In 5–17-year-old children norovirus dominated with little change over time. Of patients <5 years, those with underlying conditions constituted a larger proportion postvaccination than prevaccination (30.7% vs. 24.2%, p < .001). A complication other than dehydration, most commonly seizures, arose in 8.8% of the patients <5 years prevaccination and 11.4% postvaccination (p < .05). Rotavirus vaccination reduced the number of children <5 years requiring hospital care for gastroenteritis. We saw no replacement of rotavirus by other viruses.

17 December 2022 in Infectious Diseases
Verified
Journal Article
Closed access
SOSelma Olsson-Åkefeldt
Selma Olsson-Åkefeldt
MÖMaria Rotzén Östlund
Maria Rotzén Östlund
BHBerit Hammas
Berit Hammas
MEMargareta Eriksson
Margareta Eriksson
RBRutger Bennet
Rutger Bennet
Background: Vaccination against rotavirus was offered in Stockholm to children born on 1 March 2014 and onwards with 85% coverage after two years. We investigated changes in nosocomial diarrhoea 2010—2018 in children admitted to Astrid Lindgren Children’s Hospital, Stockholm, Sweden. Methods: We retrospectively identified cases from diagnostic and virology department registers. Complications and chronic medical conditions were retrieved from the case records. Children <18 years of age who developed diarrhoea ≥48 h after admission for another diagnosis and had a faecal sample submitted to the virology department were included. Results: There were 474 episodes of nosocomial diarrhoea. Of these, 401 (85%) occurred in children with chronic medical conditions. In children <5 years the rates of nosocomial rotavirus gastroenteritis, with 95% confidence intervals, significantly decreased from 0.34 (0.25—0.45) per 100 admissions prevaccination to 0.09 (0.04—0.17) postvaccination and from 0,66 (0.48—0.88) to 0.16 (0.07—0.30) cases per 1000 hospital days. Postvaccination norovirus became the most frequent pathogen. Virus-positive cases were more common in young children and in winter months. Conclusions: Before the initiation of rotavirus vaccination, norovirus and rotavirus were equally common causes of nosocomial diarrhoea. Postvaccination, rotavirus was reduced by approximately 75% while the frequency of other viruses did not change.